Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Drugs like Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) mimic the peptides in your body to reduce appetite and control cravings. Proteins are made up of smaller units ...

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Tirzepatide mimics two key hormones in your body, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones play essential roles after eating ...

Retatrutide and Tirzepatide represent promising peptides with potential implications in regulating metabolic functions. Their distinct mechanisms of action and possible properties in glycemic ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

outperforming established peptides like Tirzepatide and Liraglutide (Ma et al., 2025). Furthermore, Retatrutide showed promising effects in reducing diabetic nephropathy markers, inflammation ...

Tirzepatide's uptake was rapid post-launch, surpassing other GLP-1 RAs and SGLT2 inhibitors, while conventional GLMs like metformin and insulin declined. The approval of tirzepatide for type 2 ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...